深度|脑机接口“狂飙”:马斯克开启大规模量产,中国玩家集体“插脑”冲刺
Di Yi Cai Jing·2026-01-03 10:58

Core Insights - The global vision of brain-computer interface (BCI) companies, including Neuralink, extends beyond helping individuals with motor disabilities to include enabling speech for the speech-impaired and vision for the blind [4][7] - The BCI technology is experiencing a significant wave of innovation in the medical field, with advancements in both invasive and non-invasive techniques [1][9] Group 1: Technological Developments - Neuralink plans to initiate "high volume" production and streamline automated surgical processes in 2026 [1] - In China, the first clinical trial of a fully implanted BCI was completed, demonstrating significant recovery in motor functions for a patient with spinal cord injury [3] - The "North Brain No. 2" system, featuring high-throughput flexible microelectrodes, is set to enter clinical trials in 2026, targeting motor impairment patients [8] Group 2: Market Dynamics - The BCI market is projected to grow significantly, with non-invasive products currently holding 82% of the market share [9][10] - The Chinese government has issued policies to support the BCI industry, aiming for accelerated application in various sectors by 2027 [11] - Investment in the BCI sector has surged, with 16 financing events reported in 2025, totaling nearly 1 billion yuan [12] Group 3: Competitive Landscape - Neuralink's invasive BCI technology is considered a global benchmark, with its 1024-channel flexible electrode array and automated implantation robot leading the industry [5][8] - Chinese companies like JieTi Medical and BoRuiKang are emerging as competitors, with clinical trials underway, although they currently lag behind Neuralink in technology [8][13] - The valuation of leading BCI companies in China is significantly lower than that of Neuralink, with estimates around 3 billion yuan compared to Neuralink's 120 billion yuan [13] Group 4: Challenges and Future Outlook - The commercialization of BCI technology faces hurdles such as lengthy validation periods and high development costs [15] - Ethical concerns regarding data privacy and the potential for cognitive enhancement to exacerbate social inequalities are being addressed through the establishment of regulations and standards [17]